The Patent Finder

Intellikine LLC

13 patents currently held · Updated Nov 15, 2026
23 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 4 name spellings.

12
Ending by 2030
Jan 2029
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Jun 8 to 22, 2027 · next Jun 8
  • 1 fee due Sep 29, 2027
    The maintenance fee for Heterocyclic kinase inhibitors (US 9,296,742) comes due Sep 29, 2027. Unpaid by Mar 29, 2028, it lapses early.
  • 1 fee due Oct 19, 2027
    The maintenance fee for Heterocyclic Compounds and Uses Thereof (US 9,315,505) comes due Oct 19, 2027. Unpaid by Apr 19, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 8,785,456Substituted ISOQUINOLIN-1(2H)-ONES, and Methods of Use Thereof
In force
 · Low confidence
In forceLow confidence
US 9,216,982Certain Chemical Entities, Compositions and Methods
In force
 · Low confidence
In forceLow confidence
US 9,522,146Substituted ISOQUINOLIN-1(2H)-ONE Compounds, Compositions, and Methods Thereof
In force
 · Medium confidence
In forceMedium confidence
US 9,655,892Certain Chemical Entities, Compositions and Methods
In force
 · Low confidence
In forceLow confidence
US 9,822,131Certain chemical entities, compositions and methods
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,433,065Certain Chemical Entities, Compositions and Methods
In force
 · Medium confidence
In forceMedium confidence
US 9,206,182Substituted ISOQUINOLIN-1(2H)-ONE Compounds, Compositions, and Methods Thereof
In force
 · Medium confidence
In forceMedium confidence
US 8,569,323Substituted ISOQUINOLIN-1(2H)-ONE Compounds, Compositions, and Methods Thereof
In force
 · Medium confidence
In forceMedium confidence
US 9,296,742Heterocyclic kinase inhibitors
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,703,777Certain chemical entities, compositions and methods
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 13 patents shown.
Pro members see all 13.
Pro members: see all 13 patents
Also on record, not counted in the 13: 23 patents in force now held by others · 19 lapsed for an unpaid fee · 1 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 5 abandoned · 21 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited